Comparison of Robotic and Open Lobectomy for Lung Cancer in Marginal Pulmonary Function Patients: A Single-Centre Retrospective Study

Curr Oncol. 2023 Dec 24;31(1):132-144. doi: 10.3390/curroncol31010009.

Abstract

Background: The treatment of non-small-cell lung cancer (NSCLC) patients with reduced respiratory function represents a challenge for thoracic surgeons. Minimally invasive surgery seems to be beneficial for these patients because it reduces tissue trauma and its impact on respiratory mechanics. Application of the robotic technique, the use of CO2 insufflation and longer surgical time are factors that could influence the outcomes of marginal pulmonary function patients. The objective of this study was to evaluate the impact of the robotic technique on the postoperative outcomes of patients with poor lung function.

Methods: We retrospectively collected and analyzed data from consecutive marginal respiratory function patients who underwent robotic or open lobectomy for NSCLC. Data regarding clinical, operative and postoperative details were compared between the open and robotic approaches.

Results: The outcomes of 100 patients with reduced respiratory function were evaluated, of whom 59 underwent open lobectomies and 41 underwent robotic lobectomies. Robotic lobectomy was characterized by a longer operative time, a reduced hospital stay and a lower incidence of postoperative complications (22% vs. 33.9%), when compared to the open approach.

Conclusion: Robotic lobectomy is a safe and feasible procedure for patients with marginal pulmonary function.

Keywords: FEV1; marginal respiratory function; minimally invasive surgery; non-small-cell lung cancer; postoperative complications; robotic surgery; thoracotomy.

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / surgery
  • Humans
  • Lung
  • Lung Neoplasms* / surgery
  • Retrospective Studies
  • Robotic Surgical Procedures*

Grants and funding

This research received no external funding.